Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

Cited In for PubMed (Select 10791523)


Systemic effects of inhaled corticosteroids: an overview.

Pandya D, Puttanna A, Balagopal V.

Open Respir Med J. 2014 Dec 31;8:59-65. doi: 10.2174/1874306401408010059. eCollection 2014.


TRIP-1: a regulator of osteoblast function.

Metz-Estrella D, Jonason JH, Sheu TJ, Mroczek-Johnston RM, Puzas JE.

J Bone Miner Res. 2012 Jul;27(7):1576-84. doi: 10.1002/jbmr.1611.


Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review.

Peppa M, Krania M, Raptis SA.

Integr Blood Press Control. 2011;4:7-16. doi: 10.2147/IBPC.S9486. Epub 2011 Mar 3.


Asthma and therapeutics: inhaled corticosteroids, corticosteroid osteoporosis, and the risk of fracture in chronic asthma.

Toogood JH.

Allergy Asthma Clin Immunol. 2005 Mar 15;1(1):28-33. doi: 10.1186/1710-1492-1-1-28. Epub 2005 Mar 15.


Exacerbation rate, health status and mortality in COPD--a review of potential interventions.

Seemungal TA, Hurst JR, Wedzicha JA.

Int J Chron Obstruct Pulmon Dis. 2009;4:203-23. Epub 2009 Jun 11. Review.


Relative contributions of multiple determinants to bone mineral density in men.

Chiu GR, Araujo AB, Travison TG, Hall SA, McKinlay JB.

Osteoporos Int. 2009 Dec;20(12):2035-47. doi: 10.1007/s00198-009-0895-0. Epub 2009 Mar 25.


Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study.

Kelly HW, Van Natta ML, Covar RA, Tonascia J, Green RP, Strunk RC; CAMP Research Group.

Pediatrics. 2008 Jul;122(1):e53-61. doi: 10.1542/peds.2007-3381.


Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction.

Mortimer KJ, Tattersfield AE, Tang Y, Wu K, Lewis S, Hochhaus G, Harrison TW.

Br J Clin Pharmacol. 2007 Oct;64(4):439-44. Epub 2007 Aug 15.


Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment.

Popp AW, Isenegger J, Buergi EM, Buergi U, Lippuner K.

Eur Spine J. 2006 Jul;15(7):1035-49. Review.


Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids.

Campbell IA, Douglas JG, Francis RM, Prescott RJ, Reid DM; Research Committee of the British Thoracic Society.

Thorax. 2004 Sep;59(9):761-8.


Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide.

Phillips K, Oborne J, Lewis S, Harrison TW, Tattersfield AE.

Thorax. 2004 Jan;59(1):26-30.


A population based case-control study of cataract and inhaled corticosteroids.

Smeeth L, Boulis M, Hubbard R, Fletcher AE.

Br J Ophthalmol. 2003 Oct;87(10):1247-51.


Medical treatment of vertebral osteoporosis.

Lippuner K.

Eur Spine J. 2003 Oct;12 Suppl 2:S132-41. Epub 2003 Sep 17. Review.


Stepping down inhaled corticosteroids in asthma: randomised controlled trial.

Hawkins G, McMahon AD, Twaddle S, Wood SF, Ford I, Thomson NC.

BMJ. 2003 May 24;326(7399):1115.


Pharmacokinetics and systemic effects of inhaled fluticasone propionate in chronic obstructive pulmonary disease.

Singh SD, Whale C, Houghton N, Daley-Yates P, Kirby SM, Woodcock AA.

Br J Clin Pharmacol. 2003 Apr;55(4):375-81.


Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years.

Tattersfield AE, Town GI, Johnell O, Picado C, Aubier M, Braillon P, Karlström R.

Thorax. 2001 Apr;56(4):272-8.


The ISOLDE trial. Side effects with inhaled steroids should not be forgotten.

Lipworth BJ.

BMJ. 2000 Nov 25;321(7272):1349. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk